-
1
-
-
77957227912
-
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
-
1 Gheorghiade, M., Follath, F., Ponikowski, P., et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 12 (2010), 423–433.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 423-433
-
-
Gheorghiade, M.1
Follath, F.2
Ponikowski, P.3
-
2
-
-
59649118099
-
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure
-
2 Mullens, W., Abrahams, Z., Francis, G.S., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53 (2009), 589–596.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 589-596
-
-
Mullens, W.1
Abrahams, Z.2
Francis, G.S.3
-
3
-
-
84875165977
-
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
-
3 Ambrosy, A.P., Pang, P.S., Khan, S., et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34 (2013), 835–843.
-
(2013)
Eur Heart J
, vol.34
, pp. 835-843
-
-
Ambrosy, A.P.1
Pang, P.S.2
Khan, S.3
-
4
-
-
84899473065
-
Decongestion in acute heart failure
-
4 Mentz, R.J., Kjeldsen, K., Rossi, G.P., et al. Decongestion in acute heart failure. Eur J Heart Fail 16 (2014), 471–482.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 471-482
-
-
Mentz, R.J.1
Kjeldsen, K.2
Rossi, G.P.3
-
5
-
-
84890369206
-
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial
-
5 Chen, H.H., Anstrom, K.J., Givertz, M.M., et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310 (2013), 2533–2543.
-
(2013)
JAMA
, vol.310
, pp. 2533-2543
-
-
Chen, H.H.1
Anstrom, K.J.2
Givertz, M.M.3
-
6
-
-
84871058843
-
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
-
6 Bart, B.A., Goldsmith, S.R., Lee, K.L., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367 (2012), 2296–2304.
-
(2012)
N Engl J Med
, vol.367
, pp. 2296-2304
-
-
Bart, B.A.1
Goldsmith, S.R.2
Lee, K.L.3
-
7
-
-
11144355788
-
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial
-
7 Gheorghiade, M., Gattis, W.A., O'Connor, C.M., et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291 (2004), 1963–1971.
-
(2004)
JAMA
, vol.291
, pp. 1963-1971
-
-
Gheorghiade, M.1
Gattis, W.A.2
O'Connor, C.M.3
-
8
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial
-
8 Konstam, M.A., Gheorghiade, M., Burnett, J.C. Jr., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007), 1319–1331.
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, J.C.3
-
9
-
-
33947719178
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials
-
9 Gheorghiade, M., Konstam, M.A., Burnett, J.C. Jr., et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297 (2007), 1332–1343.
-
(2007)
JAMA
, vol.297
, pp. 1332-1343
-
-
Gheorghiade, M.1
Konstam, M.A.2
Burnett, J.C.3
-
10
-
-
70349464874
-
Effects of tolvaptan on dyspnoea relief from the EVEREST trials
-
10 Pang, P.S., Konstam, M.A., Krasa, H.B., et al. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J 30 (2009), 2233–2240.
-
(2009)
Eur Heart J
, vol.30
, pp. 2233-2240
-
-
Pang, P.S.1
Konstam, M.A.2
Krasa, H.B.3
-
11
-
-
84878580083
-
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan
-
11 Hauptman, P.J., Burnett, J., Gheorghiade, M., et al. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail 19 (2013), 390–397.
-
(2013)
J Card Fail
, vol.19
, pp. 390-397
-
-
Hauptman, P.J.1
Burnett, J.2
Gheorghiade, M.3
-
12
-
-
84953343125
-
Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF trials
-
12 Felker, G.M., Mentz, R.J., Adams, K.F., et al. Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF trials. Circ Heart Fail 8 (2015), 997–1005.
-
(2015)
Circ Heart Fail
, vol.8
, pp. 997-1005
-
-
Felker, G.M.1
Mentz, R.J.2
Adams, K.F.3
-
13
-
-
79952260198
-
Diuretic strategies in patients with acute decompensated heart failure
-
13 Felker, G.M., Lee, K.L., Bull, D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
-
(2011)
N Engl J Med
, vol.364
, pp. 797-805
-
-
Felker, G.M.1
Lee, K.L.2
Bull, D.A.3
-
14
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
14 O'Connor, C.M., Starling, R.C., Hernandez, A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365 (2011), 32–43.
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
-
15
-
-
77957730950
-
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
15 Massie, B.M., O'Connor, C.M., Metra, M., et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363 (2010), 1419–1428.
-
(2010)
N Engl J Med
, vol.363
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
-
16
-
-
84871986523
-
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
-
16 Teerlink, J.R., Cotter, G., Davison, B.A., et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381 (2013), 29–39.
-
(2013)
Lancet
, vol.381
, pp. 29-39
-
-
Teerlink, J.R.1
Cotter, G.2
Davison, B.A.3
-
17
-
-
84962124728
-
Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction
-
17 Matsue, Y., Suzuki, M., Torii, S., et al. Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. J Card Fail 22 (2016), 423–432.
-
(2016)
J Card Fail
, vol.22
, pp. 423-432
-
-
Matsue, Y.1
Suzuki, M.2
Torii, S.3
-
18
-
-
84877305602
-
Markers of decongestion, dyspnea relief and clinical outcomes among patients hospitalized with acute heart failure
-
18 Kociol, R.D., McNulty, S.E., Hernandez, A.F., et al. Markers of decongestion, dyspnea relief and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 6 (2013), 240–245.
-
(2013)
Circ Heart Fail
, vol.6
, pp. 240-245
-
-
Kociol, R.D.1
McNulty, S.E.2
Hernandez, A.F.3
-
19
-
-
41149148032
-
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
-
19 Pang, P.S., Cleland, J.G., Teerlink, J.R., et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29 (2008), 816–824.
-
(2008)
Eur Heart J
, vol.29
, pp. 816-824
-
-
Pang, P.S.1
Cleland, J.G.2
Teerlink, J.R.3
-
20
-
-
84901694452
-
Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation
-
20 Miller, W.L., Mullan, B.P., Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. J Am Coll Cardiol HF 2 (2014), 298–305.
-
(2014)
J Am Coll Cardiol HF
, vol.2
, pp. 298-305
-
-
Miller, W.L.1
Mullan, B.P.2
-
21
-
-
84955196189
-
In-hospital worsening heart failure
-
21 Butler, J., Gheorghiade, M., Kelkar, A., et al. In-hospital worsening heart failure. Eur J Heart Fail 17 (2015), 1104–1113.
-
(2015)
Eur J Heart Fail
, vol.17
, pp. 1104-1113
-
-
Butler, J.1
Gheorghiade, M.2
Kelkar, A.3
-
22
-
-
84929458511
-
Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies
-
22 Davison, B.A., Metra, M., Cotter, G., et al. Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. J Am Coll Cardiol HF 3 (2015), 395–403.
-
(2015)
J Am Coll Cardiol HF
, vol.3
, pp. 395-403
-
-
Davison, B.A.1
Metra, M.2
Cotter, G.3
-
23
-
-
84939563068
-
Worsening heart failure during hospitalization for acute heart failure: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)
-
23 Kelly, J.P., Mentz, R.J., Hasselblad, V., et al. Worsening heart failure during hospitalization for acute heart failure: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). Am Heart J 170 (2015), 298–305.
-
(2015)
Am Heart J
, vol.170
, pp. 298-305
-
-
Kelly, J.P.1
Mentz, R.J.2
Hasselblad, V.3
-
24
-
-
84859634464
-
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function
-
24 Metra, M., Davison, B., Bettari, L., et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5 (2012), 54–62.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 54-62
-
-
Metra, M.1
Davison, B.2
Bettari, L.3
-
25
-
-
84881106998
-
Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion
-
25 Testani, J.M., Brisco, M.A., Chen, J., McCauley, B.D., Parikh, C.R., Tang, W.H., Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62 (2013), 516–524.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 516-524
-
-
Testani, J.M.1
Brisco, M.A.2
Chen, J.3
McCauley, B.D.4
Parikh, C.R.5
Tang, W.H.6
-
26
-
-
79960426743
-
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
-
26 Irazabal, M.V., Torres, V.E., Hogan, M.C., et al. Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney Int 80 (2011), 295–301.
-
(2011)
Kidney Int
, vol.80
, pp. 295-301
-
-
Irazabal, M.V.1
Torres, V.E.2
Hogan, M.C.3
-
27
-
-
84888646403
-
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
-
27 Boertien, W.E., Meijer, E., de Jong, P.E., et al. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int 84 (2013), 1278–1286.
-
(2013)
Kidney Int
, vol.84
, pp. 1278-1286
-
-
Boertien, W.E.1
Meijer, E.2
de Jong, P.E.3
|